---

Northern Ireland Office

Answer

Mrs. Iris Robinson: To ask the Secretary of State for Northern Ireland how much was spent on (a) haemophilia and (b) haematology drugs in the Province in each of the last five years; and what the expected spending is over the next 12 months. [198137] Angela Smith: We estimate that the total spend on treating persons with haemophilia in a hospital in- patient or day case environment in Northern Ireland was approximately £197,000 in 2002-03 and £79,000 in 2001-02. The bulk of services to haemophiliacs are, however, provided in an out-patient primary care or community environment. Blood products used by haemophiliacs are provided by the NI Blood Transfusion Service (NIBTS) and cost as follows: Total expenditure on haemophilia blood products _________________________________________________________________________________________________. £ million 2004-05 (predicted) 8.25 2003-04 7.7 2002-03 5.9 2001-02 5.2 2000-01 4.7 1999-2000 4.0 _________________________________________________________________________________________________. The total spend on chemotherapy drugs in the haematology specialty was approximately in £1.341million 2002-03 and £1.64 million in 2003-04. 2004-05 has experienced expansion in demand to approximately £3.7million. Further information is not available.

Secondary information

Type

Written question

Reference

198137; 426 c1755-6W;426 c1759-60W

Session

2003-04

Subjects

Finance Expenditure Haemophilia Medical treatments Northern Ireland Prescription drugs Haematology

Contains statistics

Yes

Link

View this Written question on www.publications.parliament.uk